WO2022137636A1 - Produit cosmétique d'écran solaire de type huile-dans-eau - Google Patents
Produit cosmétique d'écran solaire de type huile-dans-eau Download PDFInfo
- Publication number
- WO2022137636A1 WO2022137636A1 PCT/JP2021/029915 JP2021029915W WO2022137636A1 WO 2022137636 A1 WO2022137636 A1 WO 2022137636A1 JP 2021029915 W JP2021029915 W JP 2021029915W WO 2022137636 A1 WO2022137636 A1 WO 2022137636A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- mass
- total amount
- water
- cosmetics
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 108
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 66
- 230000000475 sunscreen effect Effects 0.000 title claims abstract description 26
- 239000000516 sunscreening agent Substances 0.000 title claims abstract description 24
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 69
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 64
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 27
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 22
- 150000001298 alcohols Chemical class 0.000 claims abstract description 13
- 239000006096 absorbing agent Substances 0.000 claims abstract description 11
- 239000003921 oil Substances 0.000 claims description 96
- 238000002156 mixing Methods 0.000 claims description 44
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 19
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 19
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 19
- 239000002107 nanodisc Substances 0.000 claims description 18
- 229940008099 dimethicone Drugs 0.000 claims description 17
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 11
- 239000006097 ultraviolet radiation absorber Substances 0.000 claims description 11
- 150000003384 small molecules Chemical class 0.000 claims description 9
- 230000002087 whitening effect Effects 0.000 claims description 8
- 239000002270 dispersing agent Substances 0.000 claims description 7
- 229920002545 silicone oil Polymers 0.000 claims description 5
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 claims description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims description 4
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- 150000002430 hydrocarbons Chemical class 0.000 claims description 4
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 claims description 4
- 230000005661 hydrophobic surface Effects 0.000 claims description 3
- 238000006116 polymerization reaction Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 11
- 235000019441 ethanol Nutrition 0.000 description 47
- -1 polyoxyethylene Polymers 0.000 description 44
- 239000004094 surface-active agent Substances 0.000 description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 20
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 19
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 18
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 18
- 239000008346 aqueous phase Substances 0.000 description 18
- 239000012071 phase Substances 0.000 description 18
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 14
- 239000011734 sodium Substances 0.000 description 14
- 239000004615 ingredient Substances 0.000 description 13
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 12
- 239000002211 L-ascorbic acid Substances 0.000 description 12
- 229960005070 ascorbic acid Drugs 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 238000004945 emulsification Methods 0.000 description 11
- 235000000069 L-ascorbic acid Nutrition 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 9
- 229940031569 diisopropyl sebacate Drugs 0.000 description 9
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 9
- 239000011787 zinc oxide Substances 0.000 description 9
- 229940058015 1,3-butylene glycol Drugs 0.000 description 8
- NUHMQHLCUWSBCS-UHFFFAOYSA-N 10-(16-methylheptadecoxy)-10-oxodecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCC(O)=O NUHMQHLCUWSBCS-UHFFFAOYSA-N 0.000 description 8
- ATFFFUXLAJBBDE-FQEVSTJZSA-N N-Stearoyl glutamic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O ATFFFUXLAJBBDE-FQEVSTJZSA-N 0.000 description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 8
- 235000019437 butane-1,3-diol Nutrition 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 229940072873 stearoyl glutamic acid Drugs 0.000 description 8
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 8
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 8
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 7
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 7
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 7
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 7
- 230000006750 UV protection Effects 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 229920006037 cross link polymer Polymers 0.000 description 7
- 239000006185 dispersion Substances 0.000 description 7
- 229960005323 phenoxyethanol Drugs 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000002243 precursor Substances 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 239000000377 silicon dioxide Substances 0.000 description 7
- 229960003080 taurine Drugs 0.000 description 7
- 229960000401 tranexamic acid Drugs 0.000 description 7
- 239000000230 xanthan gum Substances 0.000 description 7
- 235000010493 xanthan gum Nutrition 0.000 description 7
- 229920001285 xanthan gum Polymers 0.000 description 7
- 229940082509 xanthan gum Drugs 0.000 description 7
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- 230000001804 emulsifying effect Effects 0.000 description 6
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 5
- 230000002776 aggregation Effects 0.000 description 5
- 239000003012 bilayer membrane Substances 0.000 description 5
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 5
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000011259 mixed solution Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- OOHTWBUKWQKKEE-UHFFFAOYSA-N [6-(diethylamino)-6-hydroxy-7-oxo-7-phenylheptyl] benzoate Chemical compound C=1C=CC=CC=1C(=O)C(O)(N(CC)CC)CCCCCOC(=O)C1=CC=CC=C1 OOHTWBUKWQKKEE-UHFFFAOYSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 238000005054 agglomeration Methods 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 4
- 239000001685 glycyrrhizic acid Substances 0.000 description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 description 4
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 4
- 235000019410 glycyrrhizin Nutrition 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 3
- IZZIWIAOVZOBLF-UHFFFAOYSA-N 5-methyloxysalicylic acid Natural products COC1=CC=C(O)C(C(O)=O)=C1 IZZIWIAOVZOBLF-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000010696 ester oil Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 3
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000004973 liquid crystal related substance Substances 0.000 description 3
- 235000005152 nicotinamide Nutrition 0.000 description 3
- 239000011570 nicotinamide Substances 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 239000008385 outer phase Substances 0.000 description 3
- 229940082006 potassium cocoyl glutamate Drugs 0.000 description 3
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- GJYCVCVHRSWLNY-UHFFFAOYSA-N 2-butylphenol Chemical compound CCCCC1=CC=CC=C1O GJYCVCVHRSWLNY-UHFFFAOYSA-N 0.000 description 2
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- CIHKVMHPDDJIIP-UHFFFAOYSA-N 2-methylperoxybenzoic acid Chemical compound COOC1=CC=CC=C1C(O)=O CIHKVMHPDDJIIP-UHFFFAOYSA-N 0.000 description 2
- ZSNLEVJATWJBLU-UHFFFAOYSA-N 2-tert-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)(OC)C(=O)C1=CC=CC=C1 ZSNLEVJATWJBLU-UHFFFAOYSA-N 0.000 description 2
- AUZQQIPZESHNMG-UHFFFAOYSA-N 3-methoxysalicylic acid Chemical compound COC1=CC=CC(C(O)=O)=C1O AUZQQIPZESHNMG-UHFFFAOYSA-N 0.000 description 2
- MRIXVKKOHPQOFK-UHFFFAOYSA-N 4-methoxysalicylic acid Chemical compound COC1=CC=C(C(O)=O)C(O)=C1 MRIXVKKOHPQOFK-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 238000010306 acid treatment Methods 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- 229960004881 homosalate Drugs 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 2
- 229960000601 octocrylene Drugs 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- VBURMNYQYXSQEL-VFAVKCLXSA-N (2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one (Z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O VBURMNYQYXSQEL-VFAVKCLXSA-N 0.000 description 1
- IRVNEGRHQKGRGD-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O IRVNEGRHQKGRGD-WPXUHFOISA-N 0.000 description 1
- PBTPTBMYJPCXRQ-MGMRMFRLSA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O PBTPTBMYJPCXRQ-MGMRMFRLSA-N 0.000 description 1
- MHUOEHQATDLJFZ-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;octadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O MHUOEHQATDLJFZ-WPXUHFOISA-N 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- KKYDYRWEUFJLER-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5,6,6,7,7,10,10,10-heptadecafluorodecyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CCC(F)(F)F KKYDYRWEUFJLER-UHFFFAOYSA-N 0.000 description 1
- UAFHRUBCOQPFFM-UHFFFAOYSA-N 1-(aminomethyl)cyclohexane-1-carboxylic acid Chemical compound NCC1(C(O)=O)CCCCC1 UAFHRUBCOQPFFM-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- AYUKNFXLSTVUAB-UHFFFAOYSA-N 2-[2-[2-(2,2-dimethylpropanoyloxy)propoxy]propoxy]propyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OC(C)COC(C)COC(C)COC(=O)C(C)(C)C AYUKNFXLSTVUAB-UHFFFAOYSA-N 0.000 description 1
- JUIYTAQAHOONSH-UHFFFAOYSA-N 2-hydroxy-4-propan-2-yloxybenzoic acid Chemical compound CC(C)OC1=CC=C(C(O)=O)C(O)=C1 JUIYTAQAHOONSH-UHFFFAOYSA-N 0.000 description 1
- IXKMJGZLCSWMTD-UHFFFAOYSA-N 2-hydroxy-4-propoxybenzoic acid Chemical compound CCCOC1=CC=C(C(O)=O)C(O)=C1 IXKMJGZLCSWMTD-UHFFFAOYSA-N 0.000 description 1
- AAUQLHHARJUJEH-UHFFFAOYSA-N 2-hydroxy-5-methoxybenzoic acid Natural products COC1=CC=CC(O)=C1C(O)=O AAUQLHHARJUJEH-UHFFFAOYSA-N 0.000 description 1
- VHCJSVNQEBEVMO-UHFFFAOYSA-N 2-hydroxy-5-propoxybenzoic acid Chemical compound CCCOC1=CC=C(O)C(C(O)=O)=C1 VHCJSVNQEBEVMO-UHFFFAOYSA-N 0.000 description 1
- PKYUNJWBVAXPMG-UHFFFAOYSA-N 3-ethoxy-2-hydroxybenzoic acid Chemical compound CCOC1=CC=CC(C(O)=O)=C1O PKYUNJWBVAXPMG-UHFFFAOYSA-N 0.000 description 1
- JBRMEFWJFBHUKG-UHFFFAOYSA-N 4-[(diaminomethylideneamino)methyl]cyclohexane-1-carboxylic acid Chemical compound NC(N)=NCC1CCC(C(O)=O)CC1 JBRMEFWJFBHUKG-UHFFFAOYSA-N 0.000 description 1
- RNGFVIMNTYOBTK-UHFFFAOYSA-N 4-butoxy-2-hydroxybenzoic acid Chemical compound CCCCOC1=CC=C(C(O)=O)C(O)=C1 RNGFVIMNTYOBTK-UHFFFAOYSA-N 0.000 description 1
- DVZPQHRWOUXUPU-UHFFFAOYSA-N 4-ethoxy-2-hydroxybenzoic acid Chemical compound CCOC1=CC=C(C(O)=O)C(O)=C1 DVZPQHRWOUXUPU-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ZZKFPIOJAOEMQL-UHFFFAOYSA-N 5-ethoxy-2-hydroxybenzoic acid Chemical compound CCOC1=CC=C(O)C(C(O)=O)=C1 ZZKFPIOJAOEMQL-UHFFFAOYSA-N 0.000 description 1
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- UEQVLKWMHAYVLO-MGCOHNPYSA-N C1C[C@@H](CN)CC[C@@H]1C(=O)OC1=CC=C(O)C=C1C(O)=O Chemical compound C1C[C@@H](CN)CC[C@@H]1C(=O)OC1=CC=C(O)C=C1C(O)=O UEQVLKWMHAYVLO-MGCOHNPYSA-N 0.000 description 1
- AVWTXYWHGFHGQD-ZKCHVHJHSA-N CNC(=O)[C@H]1CC[C@H](CN)CC1 Chemical compound CNC(=O)[C@H]1CC[C@H](CN)CC1 AVWTXYWHGFHGQD-ZKCHVHJHSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- KIENGQUGHPTFGC-JLAZNSOCSA-N L-ascorbic acid 6-phosphate Chemical compound OP(=O)(O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O KIENGQUGHPTFGC-JLAZNSOCSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 241000446313 Lamella Species 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- YQINWFJNFJEWHH-UCLHFMLVSA-N OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O YQINWFJNFJEWHH-UCLHFMLVSA-N 0.000 description 1
- GAKOHFNTEXOHTP-RXSVEWSESA-N OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.OP(O)(=O)OP(O)(=O)OP(O)(O)=O Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.OP(O)(=O)OP(O)(=O)OP(O)(O)=O GAKOHFNTEXOHTP-RXSVEWSESA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 229920004482 WACKER® Polymers 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000001343 alkyl silanes Chemical class 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000013011 aqueous formulation Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940072065 ascorbic acid 2-sulfate Drugs 0.000 description 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- VJZWIFWPGRIJSN-XRHABHTOSA-N dilinoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O.CCCCC\C=C/C\C=C/CCCCCCCC(O)=O VJZWIFWPGRIJSN-XRHABHTOSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- HUVYTMDMDZRHBN-UHFFFAOYSA-N drometrizole trisiloxane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)CC(C)CC1=CC(C)=CC(N2N=C3C=CC=CC3=N2)=C1O HUVYTMDMDZRHBN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 229960000655 ensulizole Drugs 0.000 description 1
- SBRXLTRZCJVAPH-UHFFFAOYSA-N ethyl(trimethoxy)silane Chemical compound CC[Si](OC)(OC)OC SBRXLTRZCJVAPH-UHFFFAOYSA-N 0.000 description 1
- OOCHRDQHTSHBJV-UHFFFAOYSA-N ethyl-dimethoxy-(2,2,2-trifluoroethoxy)silane Chemical compound CC[Si](OC)(OC)OCC(F)(F)F OOCHRDQHTSHBJV-UHFFFAOYSA-N 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- CZWLNMOIEMTDJY-UHFFFAOYSA-N hexyl(trimethoxy)silane Chemical compound CCCCCC[Si](OC)(OC)OC CZWLNMOIEMTDJY-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- AQYSYJUIMQTRMV-UHFFFAOYSA-N hypofluorous acid Chemical compound FO AQYSYJUIMQTRMV-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000008384 inner phase Substances 0.000 description 1
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- BFXIKLCIZHOAAZ-UHFFFAOYSA-N methyltrimethoxysilane Chemical compound CO[Si](C)(OC)OC BFXIKLCIZHOAAZ-UHFFFAOYSA-N 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- QGLKJKCYBOYXKC-UHFFFAOYSA-N nonaoxidotritungsten Chemical compound O=[W]1(=O)O[W](=O)(=O)O[W](=O)(=O)O1 QGLKJKCYBOYXKC-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229940100498 polysilicone-15 Drugs 0.000 description 1
- 229920002282 polysilicones-15 Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- QXQOYJODXQCGON-UHFFFAOYSA-M potassium;2-methylperoxybenzoate Chemical compound [K+].COOC1=CC=CC=C1C([O-])=O QXQOYJODXQCGON-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- NMEPHPOFYLLFTK-UHFFFAOYSA-N trimethoxy(octyl)silane Chemical compound CCCCCCCC[Si](OC)(OC)OC NMEPHPOFYLLFTK-UHFFFAOYSA-N 0.000 description 1
- 229910001930 tungsten oxide Inorganic materials 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K8/894—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Definitions
- the present invention relates to an underwater oil type sunscreen cosmetic having improved vibration stability and water resistance in sunscreen cosmetics.
- Some amphipathic substances form spherical closures consisting of bilayer membranes (lamella liquid crystals) in the aqueous phase, and such bilayer membrane closures are called vesicles. Vesicles can retain water-soluble components inside the closed body, oil-based components can be retained inside the bilayer membrane, and can be expected to have effects such as improving the stability of the system, so they are the basis of cosmetics. It is used as an agent.
- vesicles are formed by using a specific polyoxyethylene hydrogenated castor oil derivative as an amphipathic substance, and by containing this as an emulsifier, cosmetics that are not sticky and have a good usability. Is disclosed that was obtained.
- a silicone-based surfactant can be mentioned as an amphipathic substance forming a vesicle.
- the vesicle formed by the silicone-based surfactant is preferably used because it has advantages such as a composition having no stickiness and a good usability and being easy to prepare.
- Patent Document 3 the stability of vesicles was improved by adding a water-soluble low-molecular-weight surfactant to a vesicle-containing aqueous solution previously formed by mixing an aqueous formulation and a silicone-based surfactant. Is described. Further, Patent Document 4 describes that the stability of the vesicle is improved by adding the anionic surfactant after forming the vesicle from the silicone-based surfactant.
- Patent Document 4 shows that the stability tends to decrease when the oil content is 0.4% by mass or more.
- Patent Document 5 discloses a technique of dispersing a liquid phase insoluble in water in an outer phase by a vesicle including an inner phase.
- a vesicle including an inner phase since emulsification by vesicles is unstable and there are restrictions on practical use, the amount of vesicles to be blended tends to be large, and as is generally known, stickiness due to a surfactant forming vesicles is a problem. In some cases.
- An object of the present invention is to provide an oil-in-water emulsified sunscreen cosmetic having excellent stability and water resistance and high ultraviolet protection.
- the inventors have used a vesicle formed by a specific silicone-based surfactant in the presence of a specific aqueous component in an oil-in-water emulsified composition as a precursor.
- a specific silicone-based surfactant in the presence of a specific aqueous component in an oil-in-water emulsified composition as a precursor.
- nanodisc is a flat plate-shaped lamellar liquid crystal closure whose precursor is a vesicle (lamellar liquid crystal spherical closure) formed by an amphipathic substance, and contains a water-soluble component inside the closure. However, it refers to a substance having an amphipathic group at the edge portion. Nanodiscs exist as precursor vesicles in oil-free compositions, and the vesicles undergo structural changes (hereinafter also referred to as "transfers”) to nanodisks by adding oil and emulsifying.
- an anionic surfactant and an oil component are added to a vesicle aqueous dispersion obtained by mixing an aqueous component selected from a monohydric alcohol and a divalent alcohol with a polyoxyalkylene-modified silicone to form a vesicle. It is obtained by adding and dispersing while applying a strong stirring force.
- Nanodiscs exist in a state of being adsorbed on the oil-water interface in an emulsified state, and contribute to emulsification stability.
- the amphipathic substance forming the vesicle is a silicone-based surfactant
- the nanodisk of the present invention is also referred to as “silicone nanodisk”.
- the present invention (A) Aqueous component selected from monohydric alcohols and divalent alcohols, (B) Polyoxyalkylene modified silicone, (C) Oil containing polar oil, (D) An ultraviolet scattering agent having a hydrophobic surface, and (E) Containing anionic surfactant,
- Aqueous component selected from monohydric alcohols and divalent alcohols,
- B) Polyoxyalkylene modified silicone (C) Oil containing polar oil, (D) An ultraviolet scattering agent having a hydrophobic surface, and (E) Containing anionic surfactant,
- the aqueous component (A) is monohydric alcohol alone, it is 1 to 15% by mass with respect to the total amount of cosmetics, and when dihydric alcohol is alone, it is 1 to 20% by mass with respect to the total amount of cosmetics.
- the total amount is 1 to 45% by mass with respect to the total amount of cosmetics.
- the ratio of the low molecular weight oil to the total amount of the oil excluding the ultraviolet absorber is 50% or less in terms of mass ratio, which is an oil-in-water sunscreen.
- the oil-in-water emulsified cosmetic according to the present invention is characterized in that nanodisks made of the (B) polyoxyalkylene-modified silicone are attached to the oil-water interface.
- the cosmetic according to the present invention becomes an oil-in-water emulsion having a high emulsifying power by the above composition, a large amount of an ultraviolet protective agent (ultraviolet absorber and ultraviolet scattering agent) is blended in the oil phase. Can be done. In addition, vibration stability and water resistance can be improved as compared with the conventional emulsification by vesicles. Therefore, it is possible to realize a cosmetic that is more suitable for carrying. Furthermore, since the silicone nanodisc according to the present invention has sufficient emulsifying power, it is also possible to add a water-soluble agent such as a salt-type whitening agent, which tends to have poor stability when added to the aqueous phase, which is usually the outer phase. It becomes.
- a water-soluble agent such as a salt-type whitening agent
- the cosmetic according to the present invention comprises (A) an aqueous component selected from a monohydric alcohol and a divalent alcohol, (B) a polyoxyalkylene-modified silicone, (C) an oil containing polar oil, and (D) a hydrophobic surface. It is characterized by containing an ultraviolet scattering agent having and (E) an anionic surfactant.
- A an aqueous component selected from a monohydric alcohol and a divalent alcohol
- B a polyoxyalkylene-modified silicone
- C an oil containing polar oil
- D a hydrophobic surface. It is characterized by containing an ultraviolet scattering agent having and (E) an anionic surfactant.
- the (A) aqueous component (hereinafter, may be simply referred to as "(A) component”) blended in the cosmetic according to the present invention is one or more selected from monohydric alcohol and dihydric alcohol.
- the monohydric alcohol is not particularly limited as long as it is usually used for cosmetics, and examples thereof include ethyl alcohol (ethanol), normal propyl alcohol, and isopropyl alcohol, and in the present invention, ethyl alcohol is preferable.
- the divalent alcohol is not particularly limited as long as it is usually used for cosmetics, but examples thereof include 1,3-butylene glycol, dipropylene glycol and the like, and dipropylene glycol is preferable in the present invention.
- the surface of the spherical vesicles formed by the surfactant is entirely covered with hydrophilic groups, but since nanodiscs have lipophilic groups at the edges, it is difficult to generate nanodisks in water.
- the solvent effect hydrophilizes the surfactant (polyether-modified silicone in the present invention), resulting in accelerated transfer from spherical vesicles to nanodisks.
- the blending amount is 1 to 15% by mass with respect to the total amount of cosmetics
- the divalent alcohol is used alone
- the blending amount is 1 to 15% by mass with respect to the total amount of cosmetics. It is 1 to 20% by mass.
- the total blending amount is 1 to 45% by mass, preferably 1 to 35% by mass, based on the total amount of the cosmetics. More preferably, it is preferably blended with the concentration of the monohydric alcohol and the divalent alcohol satisfying the following formula (1) as the upper limit.
- the blending amount of monohydric alcohol alone, the blending amount of dihydric alcohol alone, and the total blending amount of monohydric alcohol and divalent alcohol is less than 1% by mass, vesicles may not be generated or the structure may be disturbed and emulsification may not be possible. .. Further, when the blending amount of the monohydric alcohol alone exceeds 15% by mass or when the blending amount of the dihydric alcohol alone exceeds 20% by mass, the blending ratio of the monohydric alcohol and the dihydric alcohol is further in the above formula (1).
- the (B) polyoxyalkylene-modified silicone (hereinafter, may be simply referred to as “component (B)”) blended in the cosmetic according to the present invention has a polysiloxane structure as a hydrophobic group and a polyoxyalkylene as a hydrophilic group. It is a surfactant having a structure, and is preferably a water-soluble silicone-based surfactant in which a part of the methyl group of dimethicone is replaced with polyethylene glycol. Specifically, it is expressed by the following equation (2).
- R 1 is hydrogen or an alkyl group having 1 to 6 carbon atoms, and may be the same or independently different from each other.
- At least one of A is the formula (3): -(CH 2 ) a- (C 2 H 4 O) b- (C 3 H 6 O) c-R 2 (3)
- the other A is a hydrogen or an alkyl group having 1 to 6 carbon atoms, which may be the same or independently different from each other.
- R 2 in the formula (3) is hydrogen or an alkyl group having 1 to 6 carbon atoms, a is an integer of 1 to 6, b is an integer of 0 to 50, c is an integer of 0 to 50, and b + c is at least 5 or more. be.
- m is an integer of 1 to 200
- n is an integer of 0 to 50.
- the (B) polyoxyalkylene-modified silicone of the present invention preferably has an HLB of less than 10 in the HLB calculation according to the Griffin formula.
- PEG-12 dimethicone in which c is 0 and b is 12 in the above formula (3) is particularly preferable. Further, it is more preferable that PEG-12 dimethicone has an HLB of less than 10.
- Examples of commercially available products of PEG-12 dimethicone include DOWNSIL TM ES-5373, SH3772M, SH3773M, SH3775M (all manufactured by Dow Toray), IM-22 (manufactured by Wacker Chemical Co., Ltd.) and the like.
- the blending amount of the component (B) is not particularly limited as long as it can form a vesicle that is a precursor of nanodisks, but is, for example, 0.1 to 5.0% by mass, preferably 0, based on the total amount of cosmetics. .3 to 3.0% by mass, more preferably 0.8 to 2.0% by mass. If the blending amount is less than 0.1% by mass, vesicles may not be sufficiently formed, and if it exceeds 5.0% by mass, the stability of the vesicles may be inferior.
- the cosmetic according to the present invention contains nanodiscs made of the surfactant of the component (B).
- Vesicles which are precursors of nanodisks, can be formed by a conventional method. Specifically, a vesicle composed of the component (B) is formed by mixing and stirring (A) the aqueous component and (B) the polyoxyalkylene-modified silicone.
- a vesicle composed of the component (B) is formed by mixing and stirring (A) the aqueous component and (B) the polyoxyalkylene-modified silicone.
- water or an aqueous component usually used in cosmetics may be blended in an amount within a range that does not impair the stability of the vesicle.
- the average particle size of the vesicle is not particularly limited, but is usually about 30 nm to 150 nm.
- the (C) oil component (hereinafter, may be simply referred to as “(C) component”) blended in the cosmetics according to the present invention refers to an oil content that contains at least polar oil indispensable.
- the oil content (C) of the present invention contains a low molecular weight oil content
- the ratio of the low molecular weight oil content to the total amount of the oil content excluding the ultraviolet absorber shall be 50% or less in terms of mass ratio. Needs.
- Examples of the polar oil blended in the cosmetics according to the present invention include ester oils, particularly ester oils having an IOB value of about 0.1 to 0.6, and oil-soluble and polar ultraviolet absorbers.
- ester oil having an IOB value of about 0.1 to 0.6 are not limited, but are limited to diisopropyl sebacate, pentaerythrityl tetraethylhexanoate, cetyl ethylhexanate, jojoba oil, and di (phytosteryl / octyl) lauroyl glutamate.
- oil-soluble and polar UV absorber may be those normally blended in sunscreen cosmetics, and are not particularly limited, but specific examples include ethylhexyl methoxycinnamate, octocrylene, and dimethico.
- organic UV absorbers such as butylphenol, phenylbenzimidazole sulfonic acid, homosalate, ethylhexyl salicylate, terephthalylidenedicanfursulfonic acid, and drometrizoletrisiloxane.
- the polar oil used in the present invention one kind or a combination of two or more kinds may be used.
- the oil (C) of the present invention may further contain one or more selected from hydrocarbon oils and silicone oils.
- hydrocarbon oil examples include isododecane, isohexadecane, hydrogenated polydecene, isoparaffin, liquid paraffin, ozokerite, squalane, pristane, paraffin, ceresin, squalane, petrolatum, microcrystalline wax and the like.
- silicone oil examples include chain polysiloxane (eg, dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane, etc.) and cyclic polysiloxane (eg, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethyl, etc.).
- chain polysiloxane eg, dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane, etc.
- cyclic polysiloxane eg, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethyl, etc.
- Silicone resin forming a three-dimensional network structure, silicone rubber, various modified polysiloxanes (amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, fluorine-modified polysiloxane, etc.), acrylic Examples include silicones.
- the ratio of the low molecular weight oil to the total amount of the oil excluding the ultraviolet absorber is set to 50% or less in terms of mass ratio. There must be. This is because if the ratio of the small molecule oil to the total amount of the oil excluding the ultraviolet absorber exceeds 50%, sufficient vibration stability cannot be obtained. Since it is not necessary to add a small molecule oil as an oil in the cosmetic according to the present invention, the lower limit of the ratio of the small molecule oil to the total amount of the oil excluding the ultraviolet absorber is 0%. ..
- the small molecule oil content refers to an oil content having a volatilization rate at 25 ° C. and a weight change rate of 30% or more per hour.
- the volatilization rate refers to the value of the rate of change in weight per hour measured under the condition of 25 ° C. by placing a filter paper on a glass petri dish, dropping about 0.2 g of a sample, and using a gravimetric method.
- Specific examples of the small molecule oil include isododecane, low-viscosity volatile silicone (low-viscosity dimethicone) having an average degree of polymerization of less than 650, and the like.
- Examples of commercially available small molecule oil products include Creasil ID CG (manufactured by Shima Trading Co., Ltd.) and KF-96L-1.5CS (manufactured by Shin-Etsu Chemical Co., Ltd.).
- the volatilization rate of Creasil ID CG is 90% or more, and the volatilization rate of KF-96L-1.5CS is about 50%.
- At least polar oil may be included as the oil component (C) of the present invention. Therefore, the cosmetic of the present invention includes an embodiment containing only polar oil as an oil component.
- the amount of the oil (C) blended in the cosmetic according to the present invention is not particularly limited as long as it is an amount normally used for blending an ultraviolet scattering agent in the oil phase, but for example, with respect to the total amount of the cosmetic. It is mentioned that it is 1 to 40% by mass. (C) If the blending amount of the oil exceeds 40% by mass, the stability and usability tend to decrease.
- a UV absorber When a UV absorber is blended, it is preferably 1% by mass or more, or 3 to 30% by mass or 5 to 25, based on the total amount of the cosmetic, from the viewpoint of obtaining a sufficient UV protection effect by the UV absorber. It is more preferable to use% by mass.
- the (D) ultraviolet scattering agent (hereinafter, may be simply referred to as “(D) component”) blended in the cosmetic according to the present invention is not particularly limited, but is appropriately selected from those usually used in cosmetics. be able to. Specific examples include metal oxides such as titanium oxide, zinc oxide, iron oxide, cerium oxide, and tungsten oxide. In the present invention, titanium oxide and zinc oxide are preferable.
- the (D) ultraviolet scattering agent used in the present invention may be either untreated or hydrophobized as long as the surface of the particles is hydrophobic.
- Various types of hydrophobizing surface treatments can be used to hydrophobize the surface.
- Examples of the method for hydrophobizing surface treatment include silicone oils such as methylhydrogenpolysiloxane, dimethylpolysiloxane, and methylphenylpolysiloxane, and methyltrimethoxysilane, ethyltrimethoxysilane, hexyltrimethoxysilane, octyltrimethoxysilane, and the like.
- the blending amount of the component (D) is not particularly limited, but is usually 1% by mass or more, for example, 1 to 30% by mass, preferably 1 to 20% by mass with respect to the total amount of the cosmetic. If the blending amount is less than 1% by mass, it is difficult to obtain a sufficient UV protection effect, and if it exceeds 30% by mass, the stability tends to deteriorate. Since the cosmetic according to the present invention has excellent emulsification stability, it is possible to add an ultraviolet scattering agent exceeding 10% by mass.
- the cosmetic according to the present invention is a powder-type composition in oil in water in which (D) an ultraviolet scattering agent is dispersed in oil droplets as an internal phase.
- the oil phase is preferably 1 to 50% by mass with respect to the total amount of the cosmetics.
- the (E) anionic surfactant (hereinafter, may be simply referred to as "(E) component") blended in the cosmetics according to the present invention may be any one usually used for cosmetics, and the above-mentioned ( B) A surfactant other than a silicone-based surfactant such as polyoxyalkylene-modified silicone, which has an anionic hydrophilic group such as a carboxylic acid, a sulfonic acid, and a surfactant having a phosphoric acid structure.
- the formulation of anionic surfactant stabilizes the nanodisc.
- an anionic surfactant having a Krafft temperature higher than room temperature.
- the silicone-based surfactant and the anionic surfactant are likely to mix and interact with each other, which tends to prevent the transfer from the vesicle to the nanodisc. be.
- a sulfonate-type anionic surfactant is preferable.
- the sulfonate-type anionic surfactant include sulfosuccinic acid diester salt, alkylallyl sulfonate, alkyl ether sulfonate, sulfosuccinic acid ester salt, acylmethyl taurine salt, acyl taurine salt, potassium cetyl phosphate, and potassium cocoyl glutamate. And so on. Among them, it is preferable to select and use from acylmethyltaurine salt, potassium cetylphosphate and potassium cocoylglutamate.
- N-acylmethyl taurine salt as the (E) anionic surfactant.
- the N-acylmethyl taurine salts represented by the following formula (4) the N-stearoyl-N-methyl taurine salt is preferable.
- the blending amount of the component (E) is preferably 0.01 to 1% by mass, more preferably 0.01 to 0.1% by mass, and 0.01 to 0. It is more preferably 06% by mass. If the blending amount is less than 0.01% by mass, the nanodisk may not be sufficiently stable, and if it exceeds 1% by mass, the vesicle that is the precursor of the nanodisk is solubilized or the formation of the nanodisk is hindered. In some cases. Further, the mixing amount ratio of (B) polyoxyalkylene-modified silicone and (E) anionic surfactant is 1: 0 in terms of mass ratio. It is preferably 01 to 1: 0.06.
- a whitening agent is added to sunscreen cosmetics, but it is generally known that when a salt-type whitening agent is added to the aqueous phase, which is the outer phase, the stability tends to deteriorate. Since the cosmetic according to the present invention is emulsified by nanodiscs formed of a specific silicone-based surfactant and the emulsifying power is enhanced by limiting the oil content to be blended, a salt-type whitening agent is blended in the aqueous phase. Even so, it has the effect of being excellent in vibration stability.
- the (F) whitening agent (hereinafter, may be simply referred to as "(F) component”) blended in the cosmetic according to the present invention is not particularly limited as long as it is normally blended in the cosmetic.
- Specific examples include L-ascorbic acid and its derivatives, tranexamic acid and its derivatives, alkoxysalicylic acid and its derivatives, glycyrrhizic acid and its derivatives, nicotinic acid and its derivatives, and the like.
- one kind or a combination of two or more kinds of the above-mentioned agents may be blended.
- L-ascorbic acid monoalkyl esters such as L-ascorbic acid monostearate, L-ascorbic acid monopalmitate, and L-ascorbic acid monoolate; L-ascorbic acid monophosphate ester, L.
- L-L-ascorbic acid monoesters such as ascorbic acid-2-sulfate ester
- L-ascorbic acid dialkyl esters such as L-ascorbic acid distearate, L-ascorbic acid dipalmitate, L-ascorbic acid dioleate
- L-ascorbic acid tri L-ascorbic acid trialkyl esters such as stearate, L-ascorbic acid tripalmitate, L-ascorbic acid triolate
- L-ascorbic acid triesters such as L-ascorbic acid triphosphate
- L-ascorbic acid 2 -L-ascorbic acid glucosides such as glucoside can be mentioned.
- L-ascorbic acid, L-ascorbic acid phosphate ester, L-ascorbic acid-2-sulfate ester, L-ascorbic acid 2-glucoside and salts thereof are preferably used.
- tranexamic acid Derivatives of tranexamic acid include dimers of tranexamic acid (eg, trans-4- (trans-aminomethylcyclohexanecarbonyl) aminomethylcyclohexanecarboxylic acid, etc.), esters of tranexamic acid and hydroquinone (eg, 4).
- tranexamic acid and a salt thereof are preferably used.
- the derivative of alkoxysalicylic acid is one in which the hydrogen atom at any of the 3-position, 4-position or 5-position of salicylic acid is substituted with an alkoxy group, and the alkoxy group as the substituent is preferably a methoxy group, an ethoxy group, or the like. It is any one of a propoxy group, an isopropoxy group, a butoxy group and an isobutoxy group, and more preferably a methoxy group or an ethoxy group.
- compound names include 3-methoxysalicylic acid, 3-ethoxysalicylic acid, 4-methoxysalicylic acid, 4-ethoxysalicylic acid, 4-propoxysalicylic acid, 4-isopropoxysalicylic acid, 4-butoxysalicylic acid, and 5-methoxysalicylic acid. , 5-ethoxysalicylic acid, 5-propoxysalicylic acid and the like.
- methoxysalicylic acid and a salt thereof are preferably used.
- Examples of the derivative of glycyrrhizic acid include salts of glycyrrhizic acid and esters of glycyrrhizic acid and higher alcohols.
- glycyrrhizic acid and salts thereof are preferably used.
- the salt of the above-mentioned drug is not particularly limited, and examples thereof include alkali metal salts such as sodium salt, potassium salt and calcium salt, alkaline earth metal salts, ammonium salts, amino acid salts and the like.
- nicotinic acid and its derivatives examples include nicotinic acid, benzyl nicotinate, nicotinic acid amide, and dl- ⁇ -tocopherol nicotinate. Nicotinamide is preferably used in the present invention.
- the blending amount of the (F) whitening agent is 0.05 to 10% by mass, preferably 0.1 to 7% by mass, and more preferably 0.5 to 5% by mass with respect to the total amount of the cosmetic. If the blending amount is less than 0.05% by mass, it is difficult to obtain a sufficient medicinal effect, and if it exceeds 10% by mass, the stability and usability tend to deteriorate.
- the (F) whitening agent of the present invention may be dissolved or dispersed in the aqueous phase together with other aqueous components.
- the cosmetic according to the present invention may contain one or more (G) dispersants.
- the dispersant include sorbitan sesquiisostearate, isostearic acid, palmitic acid, polyhydroxystearic acid and the like.
- sorbitan sesquiisostearate and isostearic acid are exemplified as particularly suitable ones, and one or both of them may be blended.
- the dispersant is a selective compounding ingredient in the cosmetics of the present invention, and therefore must be blended, but when blended, the effect of the blending is recognized and the dispersant is blended. It is preferable to add the mixture to the extent that no adverse effects such as an excessive amount of the compounding and impairing the usability are observed.
- the suitable blending amount of the (G) dispersant in the cosmetic according to the present invention is preferably about 0.01 to 1% by mass with respect to the total amount of the cosmetic.
- the water to be blended in the cosmetic according to the present invention is selected as necessary, such as ion-exchanged water, purified water, tap water, and natural water.
- the blending amount is the remaining amount (mass% with respect to the total amount of cosmetics) with respect to the sum of the essential ingredient according to the present invention and other optional blending ingredients. Generally, about 30 to 70% by mass is preferable with respect to the total amount of cosmetics.
- the oil-in-water emulsified cosmetic according to the present invention includes any other additive ingredients usually used for external skin preparations such as cosmetics and pharmaceuticals, as long as the purpose and effect of the present invention are not impaired.
- cosmetics and pharmaceuticals for example, fats and oils, waxes, higher fatty acids, higher alcohols, oil phase thickeners, surfactants, water-soluble ultraviolet absorbers, pigments, chelating agents, lower alcohols, polyhydric alcohols, pH adjusters, antioxidants, powders.
- Ingredients, fragrances and the like can be appropriately blended as needed.
- the present invention is not limited to these examples.
- (B) polyoxyalkylene-modified silicone is sufficiently mixed with (A) an aqueous component, and then the mixed solution is water containing an aqueous component other than (A) component. It can be produced as a vesicle aqueous dispersion by dropping the mixture into the phase while stirring.
- the mixed state of the (B) polyoxyalkylene-modified silicone and the (A) aqueous component may be as long as it can be confirmed that the mixed solution is transparent and in a one-phase state. For example, mixing is performed at room temperature to 90 ° C. for 1 to 30 minutes. It can be achieved by doing.
- vesicle particles having an average particle size of 30 to 150 nm measured by a dynamic light scattering method can be obtained.
- the vesicle according to the present invention can also be produced in a form in which an oily component is retained inside the bilayer membrane of the vesicle by a conventional method.
- the vesicle according to the present invention is oil-soluble by adding and mixing an oil-soluble component such as a fragrance in the step of mixing (B) polyoxyalkylene-modified silicone and (A) an aqueous component. It may be produced as a vesicle in which the component is retained in the bilayer membrane of the vesicle.
- the oil-in-water emulsified cosmetic according to the present invention is emulsified by nanodiscs transferred from vesicles by adding an anionic surfactant and oil to the aqueous phase containing vesicles and dispersing while applying strong stirring force. It was done.
- the cosmetic of the present invention is stabilized by a three-phase structure of aqueous phase-nanodisc phase-oil phase in which nanodiscs (phases) are attached to oil phases (oil droplets). Therefore, the oil-in-water emulsified cosmetic according to the present invention is characterized in that nanodiscs made of polyoxyalkylene-modified silicone are attached (localized) around the oil-water interface, that is, around the oil droplets made of the oil phase. ..
- the major axis of the nanodisk is 20 nm to 1000 nm.
- the three-phase structure of the aqueous phase-nanodisc phase-oil phase in the oil-in-water emulsified cosmetic according to the present invention can be formed by a conventional method. That is, under stirring, polyoxyalkylene-modified silicone was dropped onto an aqueous component to form vesicle particles to obtain a vesicle aqueous dispersion, and an oily component separately mixed and dissolved with an anionic surfactant in this vesicle aqueous dispersion. Is added and dispersed with a strong stirring force, the vesicles are transferred to the nanodisks, forming a three-phase structure of aqueous phase-nanodisk phase-oil phase.
- Oil droplets composed of oily components are emulsified and dispersed in the aqueous phase, and nanodisks are localized on the surface of the oil droplet particles, so that the emulsification stability is excellent and the feeling of use (freshness, non-stickiness) is also improved.
- the stirring device used for stirring is not particularly limited, and for example, a homomixer, a disper, or the like can be used.
- the vesicle particles formed in the aqueous phase can be molded into a sufficiently fine particle size by applying a strong share with the above-mentioned homomixer or the like, and uniformly dispersed in the aqueous phase.
- the degree of strong share is not particularly limited, but is usually about 5 minutes under the condition of 7,000 to 12,000 rpm by a homomixer.
- the cosmetic of the present invention is obtained by forming vesicle particles in an aqueous phase, adding an anionic surfactant to the vesicle dispersion, and then adding an oily component to emulsify. Therefore, the method for producing an oil-in-water emulsified cosmetic according to the present invention is obtained by a vesicle forming step of mixing (A) an aqueous component and (B) a polyoxyalkylene-modified silicone to form a vesicle, and a vesicle forming step.
- aqueous component and (B) a polyoxyalkylene-modified silicone are previously dissolved, and the solution is mixed with the remaining aqueous phase components to disperse the vesicles in the aqueous phase.
- a liquid may be obtained, or the vesicles are dispersed in the aqueous phase by mixing and stirring (B) the polyoxyalkylene-modified silicone in the aqueous phase containing (A) an aqueous component and an aqueous component other than (A).
- a vesicle dispersion may be obtained.
- the cosmetic according to the present invention has a fresh feeling of use peculiar to an oil-in-water emulsion and exhibits an excellent UV protection effect.
- the nanodisc-containing emulsion according to the present invention can be blended with a large amount of oil that cannot be blended with a normal solubilized product, yet a refreshing feeling of use can be obtained.
- the cosmetic according to the present invention is suitably used in various dosage forms such as creamy, milky liquid, and liquid.
- a product form it can be a skin care cosmetic having a sunscreen effect, or a make-up cosmetic such as a foundation or a foundation having a sunscreen effect.
- the present invention will be described in more detail with reference to examples below, but the present invention is not limited thereto.
- the blending amount is shown in mass% with respect to the system in which the component is blended.
- Vibration stability 30 ml of the prepared sample was placed in a resin tube, vibrated for 30 minutes under the condition of 10 Hz or higher, and the emulsified separation and powder aggregation state of the sample after standing were visually observed. The evaluation was based on the following criteria. A: No emulsification destruction or powder agglomeration is observed. B: Emulsification destruction and powder agglomeration are rarely seen. C: Emulsification destruction and powder agglomeration are observed. D: Emulsification destruction and powder agglomeration are severely observed.
- Water resistance measures the UV protection ability of UV protection agents (UV absorbers and UV scattering agents) contained in cosmetics before and after bathing, and the ratio of UV protection ability remaining after bathing (absorbance). By calculating the residual rate), the strength of water resistance was measured. Specifically, the cosmetics (samples) of each example were dropped onto a measurement plate (S plate) (5 x 5 cm V-groove PMMA plate, SPFMASTER-PA01) in an amount of 2 mg / cm 2 and applied with a finger for 60 seconds. Then, the absorbance of the coating film formed after drying for 15 minutes was measured with a U-3500 type self-recording spectrophotometer manufactured by Hitachi, Ltd.
- S plate 5 x 5 cm V-groove PMMA plate, SPFMASTER-PA01
- Abs residual rate (%) (Abs integrated value after water bath) / (Abs integrated value before water bath) ⁇ 100 Based on the calculated Abs residual rate, the determination was made according to the following criteria. A: 80% or more remains. B: 60% or more and less than 80% remains. C: Less than 60% remains.
- KF-96L-1.5CS manufactured by Shin-Etsu Chemical Co., Ltd.
- Volatilization rate approx. 50%
- 2: KF-96L-6T manufactured by Shin-Etsu Chemical Co., Ltd.
- 3: KF-96A-20CS manufactured by Shin-Etsu Chemical Co., Ltd.
- Table 1 shows cosmetics prepared by changing the amphipathic substance forming the vesicle, (E) anionic surfactant, and (C) oil.
- Example 1 and Example 2 which are the oil-in-water emulsified cosmetics of the present invention, were both excellent in vibration stability and water resistance.
- the vibration stability was excellent, but the water resistance was inferior. rice field.
- polar oil diisopropyl sebacate, cetyl ethylhexanate, ultraviolet absorber
- silicone oil or hydrocarbon oil is blended in addition to polar oil as an oil component.
- All of the cosmetics of Examples 8 to 10 had excellent vibration stability and water resistance. As shown in Example 7, it was confirmed that excellent vibration stability and water resistance can be obtained by blending polar oil without containing an ultraviolet absorber.
- KF-96L-1.5CS manufactured by Shin-Etsu Chemical Co., Ltd.
- Volatilization rate approx. 50%
- 2: KF-96L-6T manufactured by Shin-Etsu Chemical Co., Ltd.
- 3: KF-96A-20CS manufactured by Shin-Etsu Chemical Co., Ltd.
- Table 2 shows cosmetics prepared by changing the ratio of small molecule oil to the total amount of oil excluding ultraviolet absorbers. Comparison of cosmetics containing isododecane with a volatilization rate of 90% or more, which is a low molecular weight oil, or dimethicone with a volatility rate of about 50%, in which the ratio of these low molecular weight oils to the total amount of oils excluding UV absorbers exceeds 50%. In the cosmetics of Example 5, Comparative Example 6 and Comparative Example 7, the vibration stability was significantly reduced. On the other hand, cosmetics in which the ratio of the small molecule oil content to the total amount of oil excluding the ultraviolet absorber is 50% (Example 12, Example 14, Example 15) and cosmetics in which the ratio is 25% (Example 13, Implementation). All of Examples 16) had sufficient vibration stability.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202180079224.4A CN116710042A (zh) | 2020-12-25 | 2021-08-16 | 水包油型防晒化妆品 |
JP2022571035A JPWO2022137636A1 (fr) | 2020-12-25 | 2021-08-16 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPPCT/JP2020/048752 | 2020-12-25 | ||
JP2020048752 | 2020-12-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022137636A1 true WO2022137636A1 (fr) | 2022-06-30 |
Family
ID=82158901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2021/029915 WO2022137636A1 (fr) | 2020-12-25 | 2021-08-16 | Produit cosmétique d'écran solaire de type huile-dans-eau |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2022137636A1 (fr) |
CN (1) | CN116710042A (fr) |
WO (1) | WO2022137636A1 (fr) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009102236A (ja) * | 2007-10-22 | 2009-05-14 | Shiseido Co Ltd | 水中油型乳化組成物及びその製造方法 |
JP2014070032A (ja) * | 2012-09-28 | 2014-04-21 | Shiseido Co Ltd | 水中油型乳化組成物 |
JP2014214134A (ja) * | 2013-04-26 | 2014-11-17 | 株式会社 資生堂 | 水性組成物 |
JP2018076308A (ja) * | 2016-10-28 | 2018-05-17 | ロート製薬株式会社 | 外用組成物 |
-
2021
- 2021-08-16 CN CN202180079224.4A patent/CN116710042A/zh active Pending
- 2021-08-16 JP JP2022571035A patent/JPWO2022137636A1/ja active Pending
- 2021-08-16 WO PCT/JP2021/029915 patent/WO2022137636A1/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009102236A (ja) * | 2007-10-22 | 2009-05-14 | Shiseido Co Ltd | 水中油型乳化組成物及びその製造方法 |
JP2014070032A (ja) * | 2012-09-28 | 2014-04-21 | Shiseido Co Ltd | 水中油型乳化組成物 |
JP2014214134A (ja) * | 2013-04-26 | 2014-11-17 | 株式会社 資生堂 | 水性組成物 |
JP2018076308A (ja) * | 2016-10-28 | 2018-05-17 | ロート製薬株式会社 | 外用組成物 |
Also Published As
Publication number | Publication date |
---|---|
CN116710042A (zh) | 2023-09-05 |
JPWO2022137636A1 (fr) | 2022-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2915524B1 (fr) | Cosmétique d'écran solaire | |
KR101801410B1 (ko) | W/o 유화 화장료 | |
EP2559426B1 (fr) | Composition d'émulsion eau dans l'huile | |
WO2007060823A1 (fr) | Préparation à usage externe pour la peau | |
JP2010530456A (ja) | 安定した高内相エマルジョンおよびその組成物 | |
JP6878462B2 (ja) | 水中油型乳化化粧料 | |
WO2013065644A1 (fr) | Produit cosmétique | |
JP6877537B2 (ja) | 油中水型化粧料 | |
JP7347993B2 (ja) | 日焼け止め用組成物 | |
JP7075261B2 (ja) | O/w/o型乳化化粧料 | |
JP6418626B2 (ja) | 油中水型乳化組成物及び該組成物を用いた油中水型乳化化粧料 | |
JP6831737B2 (ja) | 水中油型化粧料 | |
WO2022137636A1 (fr) | Produit cosmétique d'écran solaire de type huile-dans-eau | |
JP7381457B2 (ja) | 温感化粧料 | |
JP2013256450A (ja) | 粉末化粧料およびその製造方法 | |
WO2022137637A1 (fr) | Produit cosmétique émulsifié de type huile dans l'eau | |
JP2017031080A (ja) | 油中水型皮膚外用剤 | |
TW202002943A (zh) | 溫感化妝品 | |
JP7108454B2 (ja) | 水放出性油中水型乳化化粧料 | |
WO2022264841A1 (fr) | Produit cosmétique du type émulsion huile-dans-l'eau | |
WO2022224672A1 (fr) | Produit cosmétique émulsifié huile dans l'eau | |
JP7150699B2 (ja) | 温感化粧料 | |
WO2022137638A1 (fr) | Produit cosmétique émulsifié de type huile dans l'eau | |
JP6935202B2 (ja) | 油中水型日焼け止め料 | |
JPH107521A (ja) | 乳化化粧料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21909796 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022571035 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202180079224.4 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21909796 Country of ref document: EP Kind code of ref document: A1 |